These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10465726)

  • 1. Lipids and progressive renal disease: the cardio-renal link.
    Keane WF
    Am J Kidney Dis; 1999 Aug; 34(2):xliii-xlvi. PubMed ID: 10465726
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins and the kidney.
    Wheeler DC
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):579-84. PubMed ID: 9818207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-induced glomerular injury.
    Guijarro C; Keane WF
    Nephron; 1994; 67(1):1-6. PubMed ID: 8052348
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipids, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, and progression of renal failure.
    Massy ZA; Guijarro C; O'Donnell MP; Kasiske BL; Keane WF
    Adv Nephrol Necker Hosp; 1997; 27():39-56. PubMed ID: 9408441
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations for the treatment of lipid disorders in patients on peritoneal dialysis. ISPD guidelines/recommendations. International Society for Peritoneal Dialysis.
    Fried L; Hutchison A; Stegmayr B; Prichard S; Bargman JM
    Perit Dial Int; 1999; 19(1):7-16. PubMed ID: 10201335
    [No Abstract]   [Full Text] [Related]  

  • 6. The conundrum of statins in chronic kidney disease.
    Bell S; Deighan CJ
    Scott Med J; 2010 Feb; 55(1):30-3. PubMed ID: 20218278
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipid-lowering therapy in chronic kidney disease].
    Fernández-Vega F
    Nefrologia; 2004; 24 Suppl(6):113-26, 187-235. PubMed ID: 15696902
    [No Abstract]   [Full Text] [Related]  

  • 8. Second International Symposium on Lipids, Atherosclerosis and the Kidney: summary of scientific presentations.
    Klahr S; D'Amico G
    Nephrol Dial Transplant; 1994; 9(11):1660-3. PubMed ID: 7870362
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction.
    Vogt L; Laverman GD; Dullaart RP; Navis G
    Nephrol Dial Transplant; 2004 Jan; 19(1):5-8. PubMed ID: 14671028
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatments for dyslipidemia associated with kidney disease].
    Hirano T; Yoshino G
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():748-52. PubMed ID: 11347167
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.
    Wheeler DC
    J Nephrol; 2001; 14 Suppl 4():S70-5. PubMed ID: 11798150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic kidney disease and statins].
    Matovinović MS
    Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidemia and its management in renal disease.
    Massy ZA; Kasiske BL
    Curr Opin Nephrol Hypertens; 1996 Mar; 5(2):141-6. PubMed ID: 8744535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
    Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pleiotrophic effect of anti-hyperlipemic agents].
    Morishita R
    Nihon Naika Gakkai Zasshi; 2001 Oct; 90(10):2017-22. PubMed ID: 11769493
    [No Abstract]   [Full Text] [Related]  

  • 16. Do statins prevent both cardiovascular disease and fracture?
    Cummings SR; Bauer DC
    JAMA; 2000 Jun; 283(24):3255-7. PubMed ID: 10866875
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosuvastatin-induced arrest in progression of renal disease.
    Vidt DG; Cressman MD; Harris S; Pears JS; Hutchinson HG
    Cardiology; 2004; 102(1):52-60. PubMed ID: 15073451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
    Margaritis M; Antoniades C
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521
    [No Abstract]   [Full Text] [Related]  

  • 19. The link between lipids, statins and cancer: is there a role for cardio-oncology?
    Jahangir E; Polin NM; Lavie CJ; Fazio S
    Future Cardiol; 2015 Jul; 11(4):389-93. PubMed ID: 26239431
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
    Rabar S; Harker M; O'Flynn N; Wierzbicki AS;
    BMJ; 2014 Jul; 349():g4356. PubMed ID: 25035388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.